leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 01:59:07 - browse：42

Adam's take main illustration — Molly Ferguson/STAT

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in the most flattering terms possible.

The drug, called sonelokimab, was “changing the game” for the treatment of a debilitating skin condition called hidradenitis suppurativa, or HS, said Moonlake CEO Jorge Santos da Silva, on a call for investors and analysts. The drug’s benefit for patients placed it “at the top of the heap,” he added.

For other, equally important data from the same study that did not fit Moonlake’s home-run narrative, the company took a DIY approach. Curious about how sonelokimab performed against a treatment that’s already approved for HS? Pull out a calculator and do the math yourself. How badly did a higher dose of the drug underperform a lower dose? Take a guess.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Insurer loopholes limit power of law against surprise medical bills

hotspot

focus

WSS

Microsoft strikes partnership with Duke Health to advance health AI

Insurer loopholes limit power of law against surprise medical bills

Treeline, Josh Bilenker's next biotech, is cloaked in mystery

Microsoft strikes partnership with Duke Health to advance health AI

Microsoft strikes partnership with Duke Health to advance health AI

'Ancient DNA,' 23andMe reveal African American ancestries

focus

leisure time

knowledge

Sports medicine is finally prioritizing gender equality

Scientists uncover potential path to treating deadly childhood tumor

Tori Bowie and the unacceptable rates of Black maternal death

Mass General Brigham physicians react to latest merger step

At least 13 dead in Texas as scorching temps continue

Republican states more likely to report Covid vaccine side effects

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

First Opinion on colorectal cancer screening: letter and response

Sports medicine is finally prioritizing gender equality

Oral obesity drug from Viking Therapeutics hits key early target

focus

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Trial using CRISPR to edit HIV out of cells disappoints

Multiple sclerosis has subtypes with different best treatments: study

Attacks on the drug industry will lead to fewer breakthroughs

Study: Black kids more likely to die after surgery than white kids

My superpower is killing ticks

knowledge

hotspot

focus

knowledge